Bioqual Other Non-Current Liabilities 2010-2024 | BIOQ
Bioqual other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Bioqual Annual Other Non-Current Liabilities
(Millions of US $) |
| 2024 |
$ |
| 2023 |
$ |
| 2022 |
$0 |
| 2021 |
$ |
| 2020 |
$ |
| 2019 |
$1 |
| 2018 |
$1 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Bioqual Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-11-30 |
|
| 2024-08-31 |
|
| 2024-05-31 |
|
| 2024-02-29 |
|
| 2023-11-30 |
|
| 2023-08-31 |
|
| 2023-05-31 |
|
| 2023-02-28 |
|
| 2022-11-30 |
|
| 2022-08-31 |
|
| 2022-05-31 |
$0 |
| 2022-02-28 |
|
| 2021-11-30 |
|
| 2021-08-31 |
|
| 2021-05-31 |
|
| 2021-02-28 |
|
| 2020-11-30 |
|
| 2020-08-31 |
|
| 2020-05-31 |
|
| 2020-02-29 |
|
| 2019-11-30 |
|
| 2019-08-31 |
|
| 2019-05-31 |
$1 |
| 2019-02-28 |
|
| 2018-11-30 |
|
| 2018-08-31 |
|
| 2018-05-31 |
$1 |
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
|
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.054B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
